RP 89 Pill (White/Round) Identification
RP 89 pill contains Buprenorphine Hydrochloride (Sublingual) in an 8 mg (base) dose. It is manufactured and marketed by Rhodes Pharmaceuticals.
Buprenorphine Hydrochloride is a partial opioid agonist medication used to treat opioid addiction and reduce withdrawal symptoms. This medication works by binding to the opioid receptors in the brain, reducing cravings and withdrawal symptoms associated with opioid addiction.
The RP 89 pill is intended for sublingual administration, meaning it is placed under the tongue and allowed to dissolve. This allows for rapid absorption into the bloodstream and efficient medication delivery.
It is important to follow the dosage instructions provided by your healthcare provider when taking this medication, as misuse or overuse can result in serious side effects or overdose.
As with any medication, there are potential side effects associated with taking the RP 89 pill. These can include nausea, vomiting, constipation, headache, dizziness, and drowsiness.
In rare cases, more serious side effects may occur, such as difficulty breathing or changes in mental status. If you experience any unusual or concerning symptoms while taking this medication, it is important to contact your healthcare provider immediately.
Overall, the RP 89 pill can be an effective treatment option for individuals struggling with opioid addiction. However, it should only be used under the guidance of a healthcare provider and in conjunction with other addiction treatment methods, such as counselling or behavioral therapy.
